Chad Moretz

4PUBLICATIONS
9CO-AUTHORS
Disease surveillanceRespiratory diseasesPacific Peoples medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 22, 2021
Continuity of Care Assessment Within a Vertically Integrated Care Management Organization Before and After COPD-Related Exacerbations.

Morgan Justice Fuoco, Richard A Mularski, Benjamin Wu

|Aug 01, 2021
Time-to-first exacerbation, adherence, and medical costs among US patients receiving umeclidinium/vilanterol or tiotropium as initial maintenance therapy for chronic obstructive pulmonary disease: a retrospective cohort study.

David Slade, Riju Ray, Chad Moretz

|Mar 17, 2021
Hospital Admission and Readmission Among US Patients Receiving Umeclidinium/Vilanterol or Tiotropium as Initial Maintenance Therapy for Chronic Obstructive Pulmonary Disease.

David Slade, Riju Ray, Chad Moretz

|Nov 05, 2020
Symptom Burden and GOLD Classification in Medicare Advantage Patients with COPD Initiating Umeclidinium/Vilanterol or Fluticasone Propionate/Salmeterol Therapy.

Chad Moretz, Beth Hahn, John White

Pageof 1

Frequent Collaborators

3 joint publications

Beth Hahn

3 joint publications

Riju Ray

2 joint publications

Guillaume Germain

2 joint publications

Mei Sheng Duh